A round burgundy crest emblem with simple gold ring detailing, plain and formal in style
A wide horizontal photograph of mountain scenery near Banff with pale turquoise sky, dark evergreen slopes, and a soft muted mood
A round burgundy crest emblem mirroring the first, with plain gold ring detailing and a formal quiet mood

Annual Scientific Meeting of the Canadian Organization of Medical Physicists — July 9–12, 2014, The Banff Centre, Banff, Alberta, Canada


The physics of image-guided radiotherapy: 2014 advances

The archived 2014 Annual Scientific Meeting of the Canadian Organization of Medical Physicists brought medical physicists, radiation oncologists, therapists, engineers and imaging specialists together in Banff. Its scientific program examined how images could be acquired, registered, interpreted and used to control a treatment beam. That focus made image-guided radiotherapy (IGRT) more than a software feature: it became a chain of physical decisions with a direct effect on dose and patient safety.

The program also sat within a wider professional meeting, with abstracts, CCPM examinations, business sessions, sponsors and social activities. For an Australian audience, the value lies in connecting those advances to everyday work in radiation oncology. Australian teams face long distances between regional centres, concentrated specialist services and fixed commissioning workloads, so a technically elegant advance matters only when it can be tested, supported and integrated.

From anatomy to motion in the treatment room

Image guidance starts with establishing where the tumour and surrounding anatomy sit. Kilovoltage cone-beam CT, megavoltage portal imaging and emerging in-room MRI offered different balances of soft-tissue contrast, dose, speed and geometric accuracy. The physical task was not simply to produce an image, but to relate its coordinate system to the treatment unit and ensure that a target contour on one scan represented the same tissue during treatment.

Respiratory motion made that relationship more demanding. Four-dimensional CT, breath-hold methods, gated delivery and real-time tracking shifted part of the motion-control problem into imaging and data processing. By 2014, these approaches were moving from technical demonstrations toward routine protocols for selected sites such as lung, liver and breast. Surface imaging added another layer by monitoring the exterior of the patient between volumetric scans.

The deeper advance was integration. A reconstructed image could now inform adaptive replanning, couch corrections and beam-delivery decisions within the clinical workflow. That integration created a new requirement for physicists: every transformation in the chain—from detector calibration to patient positioning—needed an uncertainty budget. A highly precise system still carried uncertainty if motion, latency or image registration was poorly characterised.

Making guidance measurable and safe

Quality assurance for IGRT must test more than whether an equipment item powers on. Daily tests of positioning, imaging dose, spatial accuracy and mechanical reproducibility establish the baseline, while phantom studies challenge the full imaging-to-treatment pathway. Checks should include oblique angles, gantry rotations and couch motion because small orientation errors can mimic successful registration.

Dose is an equally important part of the physics. Imaging guidance adds exposure, and that exposure must be considered alongside the therapeutic plan, the patient’s clinical context and the frequency of repeated acquisitions. Protocols can reduce unnecessary imaging by using existing images when they remain valid, choosing lower-dose projections where appropriate and avoiding redundant scans after a reliable match.

Adaptive treatment raises the question of when a plan should change. A useful review process compares delivered dose with the intended dose and identifies where anatomy, motion or setup differs from the planning assumptions. Such work links imaging quality to dosimetry: a blurred reconstruction may conceal a target boundary, while a registration error can shift a high-dose region. Clear tolerances and an audit trail are essential when these decisions affect clinical change.

Lessons from the Banff scientific program

The strength of a scientific meeting lies in the exchange between formal presentations and informal discussion. Abstracts from the 2014 COMP program showed the range of IGRT research, including imaging techniques, motion management, treatment planning, quality assurance and clinical workflow. Presentation by physicists, therapists, engineers and radiation oncologists also highlighted where apparently separate responsibilities meet at the treatment couch.

Professional components gave that exchange a broader setting. CCPM examinations, business meetings and exhibitor discussions connected education with certification, governance and the supply of equipment. That balance was important because adopting a new guidance platform involves capital planning, staff training, software validation and ongoing engineering support as well as the purchase of hardware.

Banff itself shaped the meeting’s character. Mountain weather, walks, meals and evening hospitality created informal settings in which delegates could compare implementation problems with colleagues. For delegates and partners, the archived Banff dining guide adds useful context for the social programme and the practical realities of a conference visit in the town.

Bringing the advances into Australian practice

Australian implementation begins with a familiar divide between metropolitan expertise and regional access. Major public radiation-oncology services are concentrated in Sydney, Melbourne, Brisbane and Adelaide, while patients in the Northern Territory, western Tasmania and parts of rural New South Wales may travel substantial distances for treatment. A workflow that adds frequent cone-beam CT can therefore affect both operating time and patient comfort.

The local market also shapes adoption. Capital equipment is commonly purchased through formal tenders in Australian dollars, with costs affected by exchange rates, GST, shipping and the availability of local biomedical engineering support. Service teams must consider who will maintain systems after installation, whether spare parts and software expertise are available, and how a vendor roadmap fits a public hospital’s asset plan. Staff accustomed to early-morning handovers, brisk multidisciplinary rounds and quick coffee breaks between outpatient clinics may also need realistic time estimates for imaging, review and replanning.

Regulation differs across jurisdictions, so international material should be translated rather than copied. Medical devices, including software with a medical purpose, are overseen by the Australian Therapeutic Goods Administration and the Therapeutic Goods Act 1985, while radiation facilities operate under state and territory radiation legislation, including licensing and safety requirements that vary by location. The archive’s Health Canada device update offers a useful Canadian comparator, but Australian teams must verify local approval, notification and radiation-control duties before changing clinical practice.

A working checklist for image-guided teams

The first step is to connect each proposed change to a defined clinical and technical requirement. A useful review should state what uncertainty the change addresses, who will review the images and what action will follow. The following clinical priorities help keep the daily workflow practical:

  • Calibrate imaging geometry after every detector or couch change.
  • Test registration accuracy across expected patient positions.
  • Record imaging dose alongside treatment dose.
  • Define thresholds for repeat imaging and replanning.

The second step is to assign ownership. Physics, dosimetry, therapy, engineering and radiation oncology should agree on tolerances, escalation paths and documentation. These delegation and compliance priorities support that work:

  • Name a physicist responsible for image-chain QA.
  • Maintain a log of upgrades, software changes and tests.
  • Include guidance devices in local radiation-safety procedures.
  • Audit image-guided courses against planning and delivered dose.

A final comparison should test the change against the baseline plan, routine staffing and realistic failure modes. This prevents an advance that performs well in a demonstration from creating hidden delays during a full treatment list. It also creates evidence that can be reviewed by the local radiation regulator, clinical governance group and commissioning authority.

Use the archived abstracts and scientific sessions to build a focused case for one measurable change in an Australian department. Select a technique, define the uncertainty it will reduce, assign the QA checks and circulate the findings through the physics, dosimetry and radiation-oncology teams. For centres beginning from a limited platform, the first goal can be stronger measurement of existing image-guidance accuracy rather than immediate adoption of every 2014 technology.